MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer

International Journal of Oncology

Volumn 48, Issue 5, 2016, Pages 2135-2143

  Park, Young Ran ^a,b   Lee, Soo Teik ^a,b   Kim, Se Lim ^a,b   Liu, Yu Chuan ^a,b   Lee, Min Ro ^b   Shin, Ja Hyun ^c   Seo, Seung Young ^a,b   Kim, Seong Hun ^a,b   Kim, In Hee ^a,b   Lee, Seung Ok ^a,b   Kim, Sang Wook ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University Medical School and Hospital   (South Korea)

^c Vision University of Jeonju   (South Korea)

Author keywords

Colorectal cancer; Invasion; Metastasis; MiR 9; Transmembrane 4 L6 family 1

Indexed keywords

GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; MICRORNA 9; SMALL INTERFERING RNA; TTRANSMEMBRANE 4 L6 FAMILY 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; 3' UNTRANSLATED REGION; MEMBRANE ANTIGEN; MICRORNA; MIRN92 MICRORNA, HUMAN; TM4SF1 PROTEIN, HUMAN; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CELL MIGRATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; CACO-2 CELL LINE; CELL MOTION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANTIGENS, SURFACE; CACO-2 CELLS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 84962504711     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3430     Document Type: Article

References (44)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG and Sargent DJ: Survival following recurrence in stage II and III colon cancer: Findings from the ACCENT data set. J Clin Oncol 26: 2336-2341, 2008.
3. Hellstrom I, Horn D, Linsley P, Brown JP, Brankovan V, Hellstrom KE: Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res 46: 3917-3923, 1986.
4. O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA and Meyers FJ: L6 monoclonal antibody binds prostate cancer. Prostate 37: 91-97, 1998.
5. Wright MD, Ni J and Rudy GB: The L6 membrane proteins-A new four-transmembrane superfamily. Protein Sci 9: 1594-1600, 2000.
6. Chang YW, Chen SC, Cheng EC, Ko YP, Lin YC, Kao YR, Tsay YG, Yang PC, Wu CW and Roffler SR: CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells. Int J Cancer 116: 243-252, 2005.
7. Lekishvili T, Fromm E, Mujoomdar M and Berditchevski F: The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: Implication for tumour cell motility. J Cell Sci 121: 685-694, 2008.
8. K ao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW and Roffler SR: Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res 9: 2807-2816, 2003.
9. Marken JS, Schieven GL, Hellström I, Hellström KE and Aruffo A: Cloning and expression of the tumor-associated antigen L6. Proc Natl Acad Sci USA 89: 3503-3507, 1992.
10. Allioli N, Vincent S, Vlaeminck-Guillem V, Decaussin-Petrucci M, Ragage F, Ruffion A and Samarut J: TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration. Prostate 71: 1239-1250, 2011.
11. Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Y, Omata M and Seki N: Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun 289: 876-881, 2001.
12. Ying SY, Chang DC, Miller JD and Lin SL: The microRNA: Overview of the RNA gene that modulates gene functions. Methods Mol Biol 342: 1-18, 2006.
13. Wang F, Xue X, Wei J, An Y, Yao J, Cai H, Wu J, Dai C, Qian Z, Xu Z, et al: hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 103: 567-574, 2010.
14. Zhou L, Liu F, Wang X and Ouyang G: The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci 5: 32, 2015.
15. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A and Marsh CB: MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105: 19678-19683, 2008.
16. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, et al: Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27: 3880-3888, 2008.
17. Mo JS, Alam KJ, Kang IH, Park WC, Seo GS, Choi SC, Kim HS, Moon HB, Yun KJ and Chae SC: MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells. Oncotarget 6: 2843-2855, 2015.
18. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 69: 5970-5977, 2009.
19. Aqeilan RI, Calin GA and Croce CM: miR-15a and miR-16-1 in cancer: Discovery, function and future perspectives. Cell Death Differ 17: 215-220, 2010.
20. Zhang J, Jia J, Zhao L, Li X, Xie Q, Chen X, Wang J and Lu F: Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell. Mol Carcinog: Mar 25, 2015. n/a, 2015. doi: 10.1002/mc.22317. (Epub ahead of print)
21. Mohammadi-Yeganeh S, Mansouri A and Paryan M: Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triplenegative breast cancer. Chem Biol Drug Des 86: 1185-1191, 2015.
22. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, et al: Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 7: 35, 2008.
23. Higashi T, Hayashi H, Ishimoto T, Takeyama H, Kaida T, Arima K, Taki K, Sakamoto K, Kuroki H, Okabe H, et al: miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. Br J Cancer 113: 252-258, 2015.
24. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J, Nie N, Liu B and Wu X: Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 28: 82, 2009.
25. Tagawa T, Haraguchi T, Hiramatsu H, Kobayashi K, Sakurai K, Inada K and Iba H: Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells. Biochem J 447: 449-455, 2012.
26. Zhu M, Xu Y, Ge M, Gui Z and Yan F: Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis. Cancer Sci 106: 833-839, 2015.
27. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM, et al: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401, 2009.
28. Slattery ML, Herrick JS, Mullany LE, Valeri N, Stevens J, Caan BJ, et al: An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer 137: 428-438, 2015.
29. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737-2743, 2009.
30. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 129: 2611-2620, 2011.
31. K im SL, Liu YC, Park YR, Seo SY, Kim SH, Kim IH, Lee SO, Lee ST, Kim DG and Kim SW: Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis. Int J Oncol 46: 1121-1130, 2015.
32. Liu LP, Liang HF, Chen XP, Zhang WG, Yang SL, Xu T and Ren L: The role of NF-kappaB in Hepatitis b virus X proteinmediated upregulation of VEGF and MMPs. Cancer Invest 28: 443-451, 2010.
33. K im Y, Kang H, Jang SW and Ko J: Celastrol inhibits breast cancer cell invasion via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. Cell Physiol Biochem 28: 175-184, 2011.
34. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
35. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414, 2007.
36. Duffy MJ, Maguire TM, Hill A, McDermott E and O'Higgins N: Metalloproteinases: Role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2: 252-257, 2000.
37. Hanemaaijer R, Verheijen JH, Maguire TM, Visser H, Toet K, McDermott E, O'Higgins N and Duffy MJ: Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer 86: 204-207, 2000.
38. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
39. Mc Donnell S, Chaudhry V, Mansilla-Soto J, Zeng ZS, Shu WP and Guillem JG: Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo. Clin Exp Metastasis 17: 341-349, 1999.
40. Shih SC, Zukauskas A, Li D, Liu G, Ang LH, Nagy JA, Brown LF and Dvorak HF: The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res 69: 3272-3277, 2009.
41. Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, et al: MiR-92b and miR-9/9∗ are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19: 375-383, 2009.
42. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256, 2010.
43. Shiiyama R, Fukushima S, Jinnin M, Yamashita J, Miyashita A, Nakahara S, Kogi A, Aoi J, Masuguchi S, Inoue Y, et al: Sensitive detection of melanoma metastasis using circulating microRNA expression profiles. Melanoma Res 23: 366-372, 2013.
44. Song Y, Li J, Zhu Y, Dai Y, Zeng T, Liu L, Li J, Wang H, Qin Y, Zeng M, et al: MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma. Oncotarget 5: 11669-11680, 2014.